-+ 0.00%
-+ 0.00%
-+ 0.00%

Barclays Maintains Underweight on Agilon Health, Lowers Price Target to $1

Benzinga·11/06/2025 14:25:20
Listen to the news
Barclays analyst Andrew Mok maintains Agilon Health (NYSE:AGL) with a Underweight and lowers the price target from $1.5 to $1.